Tivic Health Named Most Pioneering Bioelectronic Medicine Company by Global Health & Pharma Magazine
January 24 2023 - 9:00AM
Business Wire
Tivic Health® Systems, Inc. (“Tivic”) (Nasdaq: TIVC), a
commercial-phase health technology company that develops and
commercializes bioelectronic medicine, today announced that Global
Health & Pharma (GHP) has named Tivic Health the Most
Pioneering Bioelectronic Medicine Company of 2022.
“Thank you to the editors at GHP for again recognizing the
advantages and promise of bioelectronic medicine in treating
chronic conditions,” said Jennifer Ernst, CEO of Tivic Health. “For
years, the term 'therapeutics' has been synonymous with drugs, but
now electronic therapeutics are emerging as an important part of
the treatment landscape. Our team is committed to building a
trusted brand that delivers effective, evidence-based bioelectronic
solutions as a mainstream approach to treating common diseases and
conditions.”
Senior Editor, Sofi Bajor, of Global Health & Pharma’s
Technology Awards 2022 commented on the success of bioelectronic
medicine, and how Tivic Health is leading the way within this
sphere. “As an evolving field within the medical industry,
bioelectronic medicine is at the forefront of many minds around the
globe. This field explores how we can treat both simple and complex
health conditions in a non-invasive fashion. Utilizing low-level
electrical currents, bioelectronic medicine is the medical
treatment option of the future – today.
“Sinus pain is serious; however, with ClearUP®, we can find a
solution that does more than relieve our discomfort. Tivic Health
introduces a way for us to have long-term medical support without
the complications of invasive treatments. Their expert research and
knowledge have truly innovated the area of bioelectronic medicine.
ClearUP is the direct result of brilliant work and trailblazing
technology – and, ultimately, Tivic Health is paving the way for
generations to come,” she continued.
GHP honored Tivic Health’s ClearUP, a non-invasive, drug-free
handheld device that treats sinus pain and congestion, with its
Most Innovative Sinus Relief Solution for two consecutive years,
2022 and 2021. Previous award accolades for Tivic Health include
ClearUP being named to Fast Company’s Next Big Things in Tech 2021,
Innovation & Tech Today’s Top 50 Most Innovative Health Tech
Products 2020, TIME’s Most Innovative Products 2019, and CES
Innovation Awards Honoree 2020.
About Tivic
Tivic Health Systems, Inc. is a commercial-phase health
technology company delivering non-invasive bioelectronic treatments
that provide consumers with a choice in the treatment of
inflammation and certain other related conditions. For more
information visit https://tivichealth.com @TivicHealth.
Forward-Looking Statements
This press release may contain “forward-looking statements” that
are subject to substantial risks and uncertainties. All statements,
other than statements of historical fact, contained in this press
release are forward-looking statements. Forward-looking statements
contained in this press release may be identified by the use of
words such as “anticipate,” “believe,” “contemplate,” “could,”
“estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,”
“potential,” “predict,” “project,” “target,” “aim,” “should,”
“will” “would,” or the negative of these words or other similar
expressions, although not all forward-looking statements contain
these words. Forward-looking statements are based on Tivic Health
Systems, Inc.’s current expectations and are subject to inherent
uncertainties, risks, and assumptions that are difficult to
predict. Further, certain forward-looking statements are based on
assumptions as to future events that may not prove to be accurate.
Actual results could differ materially from those contained in any
forward-looking statement as a result of various factors,
including, without limitation: market and other conditions; supply
chain constraints; macroeconomic factors, including inflation; and
unexpected costs, charges or expenses that reduce Tivic’s capital
resources. Given these risks and uncertainties, you are cautioned
not to place undue reliance on such forward-looking statements. For
a discussion of other risks and uncertainties, and other important
factors, any of which could cause Tivic’s actual results to differ
from those contained in the forward-looking statements, see Tivic’s
filings with the SEC, including, its Annual Report on Form 10-K for
the year ended December 31, 2021, filed with the SEC on March 31,
2022, under the heading “Risk Factors”; its Registration Statement
on S-1, filed with the SEC on October 26, 2022, and amendments
thereto, under the heading “Risk Factors”; as well as the company’s
subsequent filings with the SEC. Forward-looking statements
contained in this press release are made as of this date, and Tivic
Health Systems, Inc. undertakes no duty to update such information
except as required by applicable law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230124005472/en/
Media Contact: Cheryl Delgreco
Cheryl.Delgreco@tivichealth.com 617-429-6749
Investor Contact: Hanover International, Inc.
ir@tivichealth.com
Tivic Health Systems (NASDAQ:TIVC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tivic Health Systems (NASDAQ:TIVC)
Historical Stock Chart
From Sep 2023 to Sep 2024